• Je něco špatně v tomto záznamu ?

Incidence of multidrug resistance, pathogenicity island markers, and pathoadaptive FimH mutations in uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients

A. Ghosh, M. Mukherjee,

. 2019 ; 64 (4) : 587-600. [pub] 20190305

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc19041159

Grantová podpora
757 (Sanc.)/ST/P/S&T/12G-21/2014 dated 27.11.14 Department of Science and Technology, Government of West Bengal
DST/INSPIRE Fellowship/2016/ IF160069 dated November 7,2016 Department of Science &Technology,New Delhi,Government of India

Asymptomatic uropathogenic Escherichia coli (UPECs) are the leading cause of asymptomatic bacteriuria (ABU) in humans. So this study aimed to identify and characterize ABU UPECs from hospitalized patients of Kolkata, India, with respect to their antibiogram profile, phylogeny, pathogenicity islands, and virulence factor gene acquisition and FimH mutations in comparison to symptomatic UPECs. E. coli was detected biochemically in 44.44% (20/45) and 32.26% (20/62) of urine culture-positive asymptomatic and symptomatic hospitalized individuals respectively. Ninety-five percent of the asymptomatic isolates were multidrug resistant (MDR) compared to the symptomatic isolates (100%). Significant predominance of unknown phylogroup, pathogenicity island markers (PAI IV536, PAI I CFT073), and distribution patterns of different virulence factor genes respectively was evident among both groups. A significant correlation was observed between both groups of isolates with respect to their antibiotic resistances (except imipenem, amikacin, and nitrofurantoin), prevalence of phylogenetic groups and PAIs, and virulence factor gene (fimH, papC, papEF, papGII, iucD, and cnf1) acquisition. Pathoadaptive FimH adhesin mutations, especially hot spot mutation V27A, were detected in 80% asymptomatic isolates mostly reported in symptomatic ones worldwide. Moreover, this is the first study from India that reported incidence of "Unknown" phylogroup, pathogenicity island markers, and potentially pathoadaptive FimH mutations in asymptomatic UPECs isolated from hospitalized patients which further indicated that these ABU E. coli might have originated from their symptomatic counterparts due to unbridled use of unprescribed antibiotics. Therefore, this study demands antibiotic de-escalation along with regular and intricate monitoring at the molecular level for efficient management of ABU that addresses a major public health concern.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19041159
003      
CZ-PrNML
005      
20191125121534.0
007      
ta
008      
191125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-019-00685-4 $2 doi
035    __
$a (PubMed)30835050
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Ghosh, Arunita $u Department of Biochemistry and Medical Biotechnology, School of Tropical Medicine, 108, C.R Avenue, Kolkata, 700073, India.
245    10
$a Incidence of multidrug resistance, pathogenicity island markers, and pathoadaptive FimH mutations in uropathogenic Escherichia coli isolated from asymptomatic hospitalized patients / $c A. Ghosh, M. Mukherjee,
520    9_
$a Asymptomatic uropathogenic Escherichia coli (UPECs) are the leading cause of asymptomatic bacteriuria (ABU) in humans. So this study aimed to identify and characterize ABU UPECs from hospitalized patients of Kolkata, India, with respect to their antibiogram profile, phylogeny, pathogenicity islands, and virulence factor gene acquisition and FimH mutations in comparison to symptomatic UPECs. E. coli was detected biochemically in 44.44% (20/45) and 32.26% (20/62) of urine culture-positive asymptomatic and symptomatic hospitalized individuals respectively. Ninety-five percent of the asymptomatic isolates were multidrug resistant (MDR) compared to the symptomatic isolates (100%). Significant predominance of unknown phylogroup, pathogenicity island markers (PAI IV536, PAI I CFT073), and distribution patterns of different virulence factor genes respectively was evident among both groups. A significant correlation was observed between both groups of isolates with respect to their antibiotic resistances (except imipenem, amikacin, and nitrofurantoin), prevalence of phylogenetic groups and PAIs, and virulence factor gene (fimH, papC, papEF, papGII, iucD, and cnf1) acquisition. Pathoadaptive FimH adhesin mutations, especially hot spot mutation V27A, were detected in 80% asymptomatic isolates mostly reported in symptomatic ones worldwide. Moreover, this is the first study from India that reported incidence of "Unknown" phylogroup, pathogenicity island markers, and potentially pathoadaptive FimH mutations in asymptomatic UPECs isolated from hospitalized patients which further indicated that these ABU E. coli might have originated from their symptomatic counterparts due to unbridled use of unprescribed antibiotics. Therefore, this study demands antibiotic de-escalation along with regular and intricate monitoring at the molecular level for efficient management of ABU that addresses a major public health concern.
650    _2
$a adheziny Escherichia coli $x genetika $x metabolismus $7 D018830
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a antibakteriální látky $x farmakologie $7 D000900
650    _2
$a asymptomatické nemoci $7 D058070
650    _2
$a dítě $7 D002648
650    12
$a mnohočetná bakteriální léková rezistence $7 D024901
650    _2
$a infekce vyvolané Escherichia coli $x epidemiologie $x mikrobiologie $x terapie $7 D004927
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a proteiny fimbrií $x genetika $x metabolismus $7 D036781
650    _2
$a genomové ostrovy $7 D044404
650    _2
$a hospitalizace $7 D006760
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mutace $7 D009154
650    _2
$a fylogeneze $7 D010802
650    _2
$a uropatogenní Escherichia coli $x účinky léků $x genetika $x izolace a purifikace $x metabolismus $7 D056689
650    _2
$a faktory virulence $x genetika $x metabolismus $7 D037521
650    _2
$a mladý dospělý $7 D055815
651    _2
$a Indie $x epidemiologie $7 D007194
655    _2
$a časopisecké články $7 D016428
700    1_
$a Mukherjee, Mandira $u Department of Biochemistry and Medical Biotechnology, School of Tropical Medicine, 108, C.R Avenue, Kolkata, 700073, India. mandira_71@yahoo.com.
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 64, č. 4 (2019), s. 587-600
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30835050 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191125 $b ABA008
991    __
$a 20191125121819 $b ABA008
999    __
$a ok $b bmc $g 1468242 $s 1079766
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 64 $c 4 $d 587-600 $e 20190305 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
GRA    __
$a 757 (Sanc.)/ST/P/S&T/12G-21/2014 dated 27.11.14 $p Department of Science and Technology, Government of West Bengal
GRA    __
$a DST/INSPIRE Fellowship/2016/ IF160069 dated November 7,2016 $p Department of Science &Technology,New Delhi,Government of India
LZP    __
$a Pubmed-20191125

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...